BXP Outlines $1.9B Disposition Strategy
BXP executives outlined plans to sell 23 properties and concentrate investments in “premier workplace assets” in coastal urban markets.
BXP Completes Partial Sale of AstraZeneca Research Center
Boston Properties completed its partial sale of a Kendall Square life science project that values the two-building development at over $2,000 per square foot.
Kendall Square Development Gets First Tenant
Astrazenica’s 570,000-square-foot lease at 290 Binney St. in Cambridge represents the first tenant to commit to Boston Properties’ mixed-use redevelopment of its Blue Garage property in Kendall Square, while potentially creating new opportunities for life science companies to grow in Boston’s Seaport District and Waltham.
